A Study Evaluating Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic Cancer
Status:
Terminated
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out the effects, good and/or bad, of the combination of
two drugs, gemcitabine and bosutinib, in patients with resected pancreatic cancer and whether
this combination can prevent pancreatic cancer from coming back.